The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_001130987.2(DYSF):c.1167del (p.Ser390fs)

CA10606659

290141 (ClinVar)

Gene: DYSF (HGNC:8291)
Condition: autosomal recessive limb-girdle muscular dystrophy (MONDO:0015152)
Inheritance Mode: Autosomal recessive inheritance
UUID: 75cd278c-1ee3-46ec-b86d-0516ab57e2ed
Approved on: 2025-10-06
Published on: 2025-11-11

HGVS expressions

NM_001130987.2(DYSF):c.1167del (p.Ser390fs)
NM_001130987.2:c.1167del
NC_000002.12:g.71526237del
CM000664.2:g.71526237del
NC_000002.11:g.71753367del
CM000664.1:g.71753367del
NC_000002.10:g.71606875del
NG_008694.1:g.77615del
ENST00000258104.8:c.1071del
ENST00000410020.8:c.1167del
ENST00000258104.7:c.1071del
ENST00000394120.6:c.1074del
ENST00000409366.5:c.1074del
ENST00000409582.7:c.1164del
ENST00000409651.5:c.1167del
ENST00000409744.5:c.1074del
ENST00000409762.5:c.1164del
ENST00000410020.7:c.1167del
ENST00000410041.1:c.1167del
ENST00000413539.6:c.1164del
ENST00000429174.6:c.1071del
NM_001130455.1:c.1074del
NM_001130976.1:c.1071del
NM_001130977.1:c.1071del
NM_001130978.1:c.1071del
NM_001130979.1:c.1164del
NM_001130980.1:c.1164del
NM_001130981.1:c.1164del
NM_001130982.1:c.1167del
NM_001130983.1:c.1074del
NM_001130984.1:c.1074del
NM_001130985.1:c.1167del
NM_001130986.1:c.1074del
NM_001130987.1:c.1167del
NM_003494.3:c.1071del
NM_001130455.2:c.1074del
NM_001130976.2:c.1071del
NM_001130977.2:c.1071del
NM_001130978.2:c.1071del
NM_001130979.2:c.1164del
NM_001130980.2:c.1164del
NM_001130981.2:c.1164del
NM_001130982.2:c.1167del
NM_001130983.2:c.1074del
NM_001130984.2:c.1074del
NM_001130985.2:c.1167del
NM_001130986.2:c.1074del
NM_003494.4:c.1071del
More

Pathogenic

Met criteria codes 4
PM3_Supporting PVS1 PM2_Supporting PP4_Strong

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Limb Girdle Muscular Dystrophy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for DYSF Version 2.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Limb Girdle Muscular Dystrophy VCEP
The NM_003494.4: c.1071del p.(Ser358LeufsTer17) variant in DYSF, which is also known as NM_001130987.2: c.1167del (p.Ser390LeufsTer17), is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 12/55, leading to nonsense mediated decay in a gene in which loss of function is an established disease mechanism (PVS1). This variant has been reported in one individual with a pathogenic variant in unknown phase (NM_003494.4: c.5698_5699del p.(Ser1900GlnfsTer14), 0.5 pts, PMID: 36983702) (PM3_Supporting). This patient displayed progressive muscle weakness and disease range dysferlin expression in blood monocytes, which is highly specific for DYSF-related LGMD (PP4_Strong). This variant is absent from gnomAD v.4.1.0 (PM2_Supporting). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 2.0.0; 10/06/2025): PVS1, PM3_Supporting, PP4_Strong, PM2_Supporting.
Met criteria codes
PM3_Supporting
This variant has been reported in one individual with a pathogenic variant in unknown phase (NM_003494.4: c.5698_5699del p.(Ser1900GlnfsTer14), 0.5 pts, PMID: 36983702) (PM3_Supporting).
PVS1
The NM_003494.4: c.1071del p.(Ser358LeufsTer17) variant in DYSF, which is also known as NM_001130987.2: c.1167del (p.Ser390LeufsTer17), is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 12/55 leading to nonsense mediated decay in a gene in which loss of function is an established disease mechanism (PVS1).
PM2_Supporting
This variant is absent from gnomAD v.4.1.0 (PM2_Supporting).
PP4_Strong
This patient displayed progressive muscle weakness and disease range dysferlin expression in blood monocytes, which is highly specific for DYSF-related LGMD (PP4_Strong).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.